Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
NCT00244634
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
238
Enrollment
INDUSTRY
Sponsor class
Conditions
Pediatric Hypertension
Interventions
DRUG:
candsartan cilexetil
Sponsor
AstraZeneca